ENOVIS CORP (ENOV)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ENOV
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ENOV | Former Chief Financial Officer; Director | 58 | ["Former Chief Financial Officer, Hill-Rom Holdings, Inc.","Extensive finance, accounting and risk management experience, including as a public company chief financial officer","Significant medical device and healthcare industry experience","Board leadership experience as an audit committee member and chair, nom/gov committee member and compensation committee member"] | ["Audit"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BMRN | Director, Enovis Corp. | 58 | ["Director, Option Care Health, Inc.","extensive experience serving on the boards of biotechnology and pharmaceutical organizations","financial and accounting expertise","interim Chief Financial Officer of Dentsply Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President of Finance of Mallinckrodt Pharmaceuticals","senior finance roles at Hospira, Inc. and Eli Lilly and Company","holds a B.S. in Finance","M.B.A from Indiana University"] | [] | 2026 |
| OPCH | Independent Director | 58 | ["Interim Chief Financial Officer of DENTSPLY Sirona Inc.","Senior Vice President and Chief Financial Officer of Hill-Rom Holdings, Inc.","Senior Vice President, Finance, of Mallinckrodt plc","Vice President, Global Commercial Finance of Hospira","Positions of increasing responsibility at Eli Lilly & Company","Extensive finance, accounting, and risk management experience","Significant healthcare industry experience","Experience with corporate governance matters, risk management, and management oversight"] | ["Audit and Finance Committee","Compensation Committee","Audit and Finance","Nominating and Corporate Governance"] | 2026 |
Biography sourced from the proxy statement filing.
Director since 2022 Independent | Age 58 Committees: Audit Career Highlights and Recent Business Experience Dentsply Sirona Inc. Interim Chief Financial Officer (April October 2022) Hill-Rom Holdings, Inc. Senior Vice President and Chief Financial Officer (2018 2021) Mallinckrodt Pharmaceuticals BiomEdit (private company) Director (2022 present) Northstar Medical Radioisotope (private company) Director (2024 present) Previously served in senior finance roles for Hospira, Inc. and Eli Lilly & Company Other Current Public Directorships BioMarin Pharmaceutical, Inc. (2023 present) Option Care Health, Inc. (2024 present) Other Public Directorships in the Past Five Years Syneos Health, Inc. (2022 2023) Turning Point Therapeutics (2021 2022) Specific Qualifications, Experience, Skills and Expertise Extensive finance, accounting and risk management experience, including as a public company chief financial officer Significant medical device and healthcare industry experience Board leadership experience as an audit committee member and chair, nom/gov committee member and compensation committee member